Company file

Identity

SYNAXYS

Pioneer in neuro-engineering, Synaxys has developed "5D-brain", the first reliable human in vitro model of the central nervous system that enables functional studies and replaces animal experimentation. With 5 accessible dimensions: 3D space, time, and disease phenotype, it enhances preclinical R&D studies of biotech and pharmaceutical groups, CROs and academic laboratories in neurosciences field.

Synaxys realizes preclinical assays and R&D projects to rapidly predict the response of the human nervous system before starting clinical trials. Using this proprietary model, Synaxys proposes custom pharmacology and toxicology screens on neural functions to identify the targets and actions of a compound, and compare it to reference drugs. Specifically our platform offers a wide range of electrophysiological assays with supporting microscopy, genomic and proteomic data for a comprehensive analysis. Synaxys "5D-brain" models are long lived and composed of all the neuronal cell types with their regulating elements. These intrinsic properties enable them to bring pertinent data on: Epilepsy, Parkinson, Multiple Sclerosis, Autism, Alzheimer...